Myeloid Malignancy Interest Group
The Myeloid Malignancy Interest Group is an NIH-wide multidisciplinary network of researchers and clinicians dedicated to improving early detection, diagnosis, prognosis and development of novel therapeutics for myeloid malignancies. For more information, see https://ccr.cancer.gov/myeloid-malignancies-program (external link).
Representatives of this interest group include:
- Peter D. Aplan, M.D. (external link)
- Paul Liu, Ph.D. (external link)
- Steven Z. Pavletic, M.D. (external link)
- Nirali N. Shah, M.D. (external link)
Mailing List
To join the Myeloid Malignancy Interest Group mailing list, please visit the Myeloid Malignancy Interest Group Listserv home page (external link), then click the “Subscribe or Unsubscribe” link in the right sidebar.
Chairs
- Nirali Shah, M.D. (external link), NCI-CCR
- Christopher Hourigan, M.D., D.Phil. (external link), Virginia Tech
- Steven Pavletic, M.D. (external link), NCI-CCR
Advisors
- Peter Aplan, M.D (external link), NCI-CCR
- Paul Liu, Ph.D. (external link), NHGRI
Myeloid Malignancy Interest Group site (external link)
Scientific Focus Areas
This page was last updated on Thursday, April 11, 2024